USE OF BIOLOGICAL DMARDS, BUT NOT OF CONVENTIONAL SYNTHETIC DMARDS OR STEROIDS, MAY BE RELEVANT TO INCREASED ENERGY INTAKE IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引:0
|
作者
Masuko, K. [1 ,2 ]
Mizukami, Y. [3 ]
Tohma, S. [4 ]
Matsui, T. [5 ]
机构
[1] Int Univ Hlth & Welf, Clin Res Ctr Med, Tokyo, Japan
[2] Sanno Med Ctr, Hlth Evaluat & Promot Ctr, Tokyo, Japan
[3] Sagami Womens Univ, Grad Sch Nutr Sci, Sagamihara, Kanagawa, Japan
[4] Natl Hosp Org, Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan
[5] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan
关键词
D O I
10.1136/annrheumdis-2017-eular.4603
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0333
引用
收藏
页码:1165 / 1165
页数:1
相关论文
共 50 条
  • [21] Cancers and cardiovascular diseases in patients with seropositive rheumatoid arthritis treated with JAK inhibitors, biologics, and conventional synthetic DMARDs
    Ahn, S. S.
    Han, M.
    Jung, I.
    Kim, H. W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (09) : 1908 - 1916
  • [22] SEVERITY OF COVID-19 IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BIOLOGICAL DMARDS
    Samigullina, R.
    Dadalova, A.
    Vasilenko, E.
    Mazurov, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 980 - 980
  • [23] CLINICAL PHENOTYPE AND ULTRASOUND CHARACTERISTICS OF RHEUMATOID ARTHRITIS FLARE AFTER DISCONTINUATION OF CONVENTIONAL SYNTHETIC DMARDS
    Manzo, A.
    Bugatti, S.
    Benaglio, F.
    Sakellariou, G.
    Caporali, R.
    Montecucco, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1287 - 1287
  • [24] THE REASONS FOR WITHDRAWAL OF BIOLOGICAL DMARDS ACCORDING TO THE RUSSIAN REGISTRY OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Satybaldyev, A.
    Karateev, D.
    Nassonov, E.
    Luchikhina, E.
    Lukina, G.
    Nikolenko, M.
    Bilinskaya, M.
    Dmitrieva, M.
    Bogoderova, L.
    Lapkina, N.
    Chichasova, N.
    Sorotskaya, V.
    Abdulganieva, D.
    Mukhina, R.
    Gafurova, G.
    Mazurov, V.
    Chakieva, D.
    Samigullin, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1002 - 1002
  • [25] Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis
    van Mulligen, Elise
    LANCET RHEUMATOLOGY, 2024, 6 (05): : e254 - e255
  • [26] Subgroups By the Peripheral Immunophenotyping and Different Responses to Biological Dmards in Patients with Rheumatoid Arthritis
    Kubo, Satoshi
    Nakayamada, Shingo
    Miyazaki, Yusuke
    Yoshikawa, Maiko
    Yoshinari, Hiroko
    Iwata, Shigeru
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Miyagawa, Ippei
    Nakano, Kazuhisa
    Tanaka, Yoshiya
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [27] PSYCHOLOGICAL AND BEHAVIORAL REACTIONS WHEN PATIENTS WITH RHEUMATOID ARTHRITIS START BIOLOGICAL DMARDS
    Motonaga, T.
    Mori, M.
    Mabuchi, M.
    Sakai, Y.
    Iijima, Y.
    Hidaka, T.
    Kameda, H.
    Kawahito, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1344 - 1345
  • [28] EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO DID NOT RESPOND TO SYNTHETIC AND BIOLOGICAL DMARDS IN CLINICAL PRACTICE
    Luchikhina, E. L.
    Karateev, D.
    Misiyuk, A.
    Demidova, N.
    Loukina, G.
    Abdulganieva, D.
    Baranov, A.
    Babaeva, A.
    Eystigneeva, L.
    Ivanova, O.
    Mazurov, V.
    Semagina, O.
    Sizikov, A.
    Sorotskaya, V.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 273 - 273
  • [29] COST SAVINGS ASSOCIATED WITH THE DECREASE OF USE OF BIOLOGICAL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS USING CONVENTIONAL DMARDS DURING A 5 YEAR PERIOD
    Santos-Moreno, P.
    Villarreal, L.
    Aza, A.
    Jaimes, F.
    Jaimes, J.
    Castro, C.
    Buitrago-Garcia, D.
    VALUE IN HEALTH, 2017, 20 (05) : A146 - A146
  • [30] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
    Kavanaugh, A.
    Buch, M. H.
    Combe, B.
    Bessette, L.
    Song, I. H.
    Song, Y.
    Suboticki, J.
    Nash, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 323 - 324